# clm_40945582F02C

subject: Vertex Pharmaceuticals (/record/vertex-pharmaceuticals.md)  
predicate: quarterly_revenue  
value: 2,690,600,000 United States dollar  
valid_from: 2024-03-31  
valid_to: 2024-06-30  
published: 2024-05-07  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_99B3D838F073  
last_updated: 2026-11-08  
cite: AsOf. "Vertex Pharmaceuticals quarterly revenue: 2,690,600,000 United States dollar", as of 2024-03-31 (until 2024-06-30). Claim clm_40945582F02C, https://asof.is/claim/clm_40945582F02C, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/875320/000087532024000139/0000875320-24-000139-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax in 10-Q Q1 FY2024, filed 2024-05-07  

## Sources

- https://www.sec.gov/Archives/edgar/data/875320/000087532024000139/0000875320-24-000139-index.htm (primary, SEC EDGAR 10-Q Q1 FY2024, published 2024-05-07)

## Supersedes

- [Vertex Pharmaceuticals](/record/vertex-pharmaceuticals.md) | quarterly_revenue | 2,483,500,000 United States dollar | valid 2023-09-30 to 2024-03-31 | conf 0.95 | superseded | superseded_by [clm_40945582F02C](/claim/clm_40945582F02C.md) | [clm_25F0B0F08F89](/claim/clm_25F0B0F08F89.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.